The GR supporters haven't a clue about two things, or they are so far red that they have to ignore:
1. The loss that comes from investing too early in bio-tech spec stocks
2. The loss that comes from penny stock dilution, a rinse and repeat cycle that enables management to pay themselves nicely, regardless of 99% pps drop, as in the case of actc.